D

Decipher Labs Ltd

DECIPHER
Market snapshot · 2026-08-11 15:21 UTC

6.49

+₹0.24 (+3.84%)

MARKET CAP

₹6.55 Cr

STOCK P/E

52W HIGH

₹11.38

52W LOW

₹5.00

BOOK VALUE

₹20.21

EPS

₹-3.05

ROE

-14.17%

SECTOR

Healthcare

DEBT/EQUITY

2.44

VOLUME

433

P/B RATIO

0.32x

PEG RATIO

Sector

Healthcare

Themes

Drug Manufacturers - Specialty & Generic
₹10.97₹9.56₹8.15₹6.74₹5.33VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/S
Strongly Undervalued

5Y Average

1.66

Current

0.46

Overvalued

2.06

Undervalued

0.80

P/B
Strongly Undervalued

5Y Average

0.43

Current

0.32

Overvalued

0.49

Undervalued

0.36

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹0.07 CrMar 2026

Latest net profit

₹-0.17 CrMar 2026

Latest EPS

₹-0.17Mar 2026

Net margin

-242.9%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-255.0%-170.0%-85.0%0.0%85.0%-0.30 Cr0.00 Cr0.30 Cr0.60 Cr0.90 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr0.25 Cr0.50 Cr0.75 Cr1.00 Cr₹-0₹-0₹-0₹0₹0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit-0.21 Cr-0.14 Cr-0.07 Cr0.00 Cr0.07 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-5.00 Cr0.00 Cr5.00 Cr10 Cr15 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +0.130.000.000.173.360.380.080.160.230.850.090.130.07
Expenses +0.460.110.100.073.240.500.150.250.390.790.200.130.24
Operating Profit-0.33-0.11-0.100.100.12-0.12-0.07-0.09-0.160.06-0.110.00-0.17
OPM %-253.85%58.82%3.57%-31.58%-87.50%-56.25%-69.57%7.06%-122.22%0.00%-242.86%
Other Income +0.000.010.010.000.010.000.020.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.010.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax-0.34-0.10-0.090.100.13-0.12-0.05-0.09-0.160.06-0.110.00-0.17
Tax %8.82%20.00%-22.22%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Net Profit +-0.37-0.12-0.070.090.12-0.13-0.06-0.09-0.170.06-0.12-0.01-0.17
EPS in Rs-0.37-0.12-0.070.090.12-0.13-0.06-0.09-0.170.06-0.12-0.01-0.17
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +16.43%16.43%16.43%16.43%16.43%
Public +83.57%83.57%83.58%83.59%83.57%
Jun 2026
Promoters +
Public +

Events Timeline

Board Meeting Intimation for Meeting Scheduled To Be Held On 13Th August, 2026.

Aug 06, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 16, 2026PDFCompany Reports Open

Closure of Trading Window

Jun 24, 2026PDFCompany Reports Open

Compliances-Reg.24(A)-Annual Secretarial Compliance

May 30, 2026PDFCompany Reports Open

Audited Standalone And Consolidated Financial Results & Statements For The Quarter And Year Ended 31.03.2026

May 30, 2026PDFCompany Reports Open